Viewing Study NCT02726269


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2026-02-27 @ 10:06 AM
Study NCT ID: NCT02726269
Status: COMPLETED
Last Update Posted: 2016-04-04
First Post: 2016-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico.
Sponsor: Asofarma de México S.A de C.V.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ASO HO 01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View